AIM2 and COVID-19: Our observation that two of the targeted methylated genes within EPIMISC were shared with severe adult COVID-19 cases (AIM2 and PM20D1) prompted us to investigate whether the EPIMISC signature was also present in non-pediatric COVID-19 cases.12